Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Patient Navigation for Colonoscopy Completion: Results of an RCT.

DeGroff A, Schroy PC 3rd, Morrissey KG, Slotman B, Rohan EA, Bethel J, Murillo J, Ren W, Niwa S, Leadbetter S, Joseph D.

Am J Prev Med. 2017 Sep;53(3):363-372. doi: 10.1016/j.amepre.2017.05.010. Epub 2017 Jul 1.

PMID:
28676254
2.

Inadequate Boston Bowel Preparation Scale scores predict the risk of missed neoplasia on the next colonoscopy.

Kluge MA, Williams JL, Wu CK, Jacobson BC, Schroy PC 3rd, Lieberman DA, Calderwood AH.

Gastrointest Endosc. 2018 Mar;87(3):744-751. doi: 10.1016/j.gie.2017.06.012. Epub 2017 Jun 23.

PMID:
28648575
3.

Physician Perceptions of Surveillance Follow-up Colonoscopy in Older Adults.

Le ST, Lash BR, Schroy PC 3rd, Calderwood AH.

J Am Board Fam Med. 2017 May-Jun;30(3):371-373. doi: 10.3122/jabfm.2017.03.160386.

4.

National Disparities in Colorectal Cancer Screening Among Obese Adults.

Seibert RG, Hanchate AD, Berz JP, Schroy PC 3rd.

Am J Prev Med. 2017 Aug;53(2):e41-e49. doi: 10.1016/j.amepre.2017.01.006. Epub 2017 Feb 22.

PMID:
28236517
5.

Predictors of Adherence to Post-Polypectomy Surveillance Colonoscopy.

Calderwood AH, Schroy PC, Kluge MA, Cabral HJ, Burgess JF.

J Health Care Poor Underserved. 2016;27(1):261-279.

PMID:
27763469
6.

Regarding "Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy".

Ahnen DJ, Schroy PC 3rd, Weber TK.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1668-1669. doi: 10.1016/j.cgh.2016.05.037. Epub 2016 Jun 3. No abstract available.

PMID:
27266981
7.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R.

Cancer. 2016 Sep 1;122(17):2633-45. doi: 10.1002/cncr.30080. Epub 2016 Jun 3. Review. Erratum in: Cancer. 2017 Oct 1;123(19):3857.

8.

Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.

Berger BM, Schroy PC 3rd, Dinh TA.

Clin Colorectal Cancer. 2016 Sep;15(3):e65-74. doi: 10.1016/j.clcc.2015.12.003. Epub 2015 Dec 18.

9.

Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial.

Schroy PC 3rd, Duhovic E, Chen CA, Heeren TC, Lopez W, Apodaca DL, Wong JB.

Med Decis Making. 2016 May;36(4):526-35. doi: 10.1177/0272989X15625622. Epub 2016 Jan 19.

10.

Response.

Calderwood AH, Thompson KD, Schroy PC 3rd, Lieberman DA, Jacobson BC.

Gastrointest Endosc. 2015 Sep;82(3):583-4. doi: 10.1016/j.gie.2015.04.042. No abstract available.

PMID:
26279354
11.

A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.

Schroy PC 3rd, Wong JB, O'Brien MJ, Chen CA, Griffith JL.

Am J Gastroenterol. 2015 Jul;110(7):1062-71. doi: 10.1038/ajg.2015.146. Epub 2015 May 26.

12.

Good is better than excellent: bowel preparation quality and adenoma detection rates.

Calderwood AH, Thompson KD, Schroy PC 3rd, Lieberman DA, Jacobson BC.

Gastrointest Endosc. 2015 Mar;81(3):691-699.e1. doi: 10.1016/j.gie.2014.10.032.

13.

Epidemiology of goblet cell and microvesicular hyperplastic polyps.

Qazi TM, O'Brien MJ, Farraye FA, Gould RW, Chen CA, Schroy PC 3rd.

Am J Gastroenterol. 2014 Dec;109(12):1922-32. doi: 10.1038/ajg.2014.325. Epub 2014 Oct 28.

PMID:
25350766
14.

Whites and blacks have similar risk of metachronous advanced colorectal neoplasia.

Kwah J, Schroy PC 3rd, Jacobson BC, Calderwood AH.

Dig Dis Sci. 2014 Sep;59(9):2264-71. doi: 10.1007/s10620-014-3132-4. Epub 2014 Apr 4. Erratum in: Dig Dis Sci. 2014 Oct;59(10):2604.

PMID:
24700155
15.

Boston Bowel Preparation Scale scores provide a standardized definition of adequate for describing bowel cleanliness.

Calderwood AH, Schroy PC 3rd, Lieberman DA, Logan JR, Zurfluh M, Jacobson BC.

Gastrointest Endosc. 2014 Aug;80(2):269-76. doi: 10.1016/j.gie.2014.01.031. Epub 2014 Mar 12.

16.

Validity of a Web-based educational program to disseminate a standardized bowel preparation rating scale.

Calderwood AH, Logan JR, Zurfluh M, Lieberman DA, Jacobson BC, Heeren TC, Schroy PC 3rd.

J Clin Gastroenterol. 2014 Nov-Dec;48(10):856-61. doi: 10.1097/MCG.0000000000000028.

17.

Risk assessment and clinical decision making for colorectal cancer screening.

Schroy PC 3rd, Caron SE, Sherman BJ, Heeren TC, Battaglia TA.

Health Expect. 2015 Oct;18(5):1327-38. doi: 10.1111/hex.12110. Epub 2013 Jul 30.

18.

Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital.

Schroy PC 3rd, Coe A, Chen CA, O'Brien MJ, Heeren TC.

Ann Intern Med. 2013 Jul 2;159(1):13-20. doi: 10.7326/0003-4819-159-1-201307020-00004.

19.

Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial.

Schroy PC 3rd, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvaganam SR, Coe AM, Chen CA, Chaisson CE, Pignone MP, Prout MN, Davidson PK, Heeren TC.

Am J Prev Med. 2012 Dec;43(6):573-83. doi: 10.1016/j.amepre.2012.08.018.

20.

The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy.

Schroy PC 3rd, Coe AM, Mylvaganam SR, Ahn LB, Lydotes MA, Robinson PA, Davis JT, Chen CA, Ashba J, Atkinson ML, Colditz GA, Heeren TC.

Cancer Prev Res (Phila). 2012 Aug;5(8):1044-52. doi: 10.1158/1940-6207.CAPR-12-0014. Epub 2012 Jun 11.

21.

Provider perspectives on the utility of a colorectal cancer screening decision aid for facilitating shared decision making.

Schroy PC 3rd, Mylvaganam S, Davidson P.

Health Expect. 2014 Feb;17(1):27-35. doi: 10.1111/j.1369-7625.2011.00730.x. Epub 2011 Sep 8.

22.

Colorectal cancer: Increasing colorectal cancer screening--miles to go.

Calderwood AH, Schroy PC 3rd.

Nat Rev Gastroenterol Hepatol. 2011 Jul 12;8(8):421-2. doi: 10.1038/nrgastro.2011.123. No abstract available.

PMID:
21750514
23.

Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia).

Levitzky BE, Brown CC, Heeren TC, Schroy PC 3rd.

Am J Gastroenterol. 2011 Jun;106(6):1099-106. doi: 10.1038/ajg.2011.20. Epub 2011 Feb 15.

PMID:
21326221
24.

Patient and Provider Preferences for Colorectal Cancer Screening: How Does CT Colonography Compare to Other Modalities?

Calderwood AH, Wasan SK, Heeren TC, Schroy PC 3rd.

Int J Canc Prev. 2011;4(4):307-338.

25.

Surveillance after colorectal cancer diagnosis in a safety net hospital.

Boehmer U, Harris J, Bowen DJ, Schroy PC 3rd.

J Health Care Poor Underserved. 2010 Nov;21(4):1138-51. doi: 10.1353/hpu.2010.0918.

PMID:
21099067
26.

The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable.

Fletcher RH, Nadel MR, Allen JI, Dominitz JA, Faigel DO, Johnson DA, Lane DS, Lieberman D, Pope JB, Potter MB, Robin DP, Schroy PC 3rd, Smith RA.

J Gen Intern Med. 2010 Nov;25(11):1230-4. doi: 10.1007/s11606-010-1446-2. Epub 2010 Aug 12.

27.

The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial.

Schroy PC 3rd, Emmons K, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvanaman S, Evans S, Chaisson C, Pignone M, Prout M, Davidson P, Heeren TC.

Med Decis Making. 2011 Jan-Feb;31(1):93-107. doi: 10.1177/0272989X10369007. Epub 2010 May 18.

28.

A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial.

Schroy PC 3rd, Glick JT, Robinson P, Lydotes MA, Heeren TC, Prout M, Davidson P, Wong JB.

Clin Trials. 2009 Dec;6(6):597-609. doi: 10.1177/1740774509346703. Epub 2009 Nov 23.

PMID:
19933718
29.

Water-assisted unsedated colonoscopy: does the end justify the means?

Wasan SK, Schroy PC 3rd.

Gastrointest Endosc. 2009 Mar;69(3 Pt 1):551-3. doi: 10.1016/j.gie.2008.10.045. No abstract available.

PMID:
19231498
30.

A simplified, noninvasive stool DNA test for colorectal cancer detection.

Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM.

Am J Gastroenterol. 2008 Nov;103(11):2862-70. doi: 10.1111/j.1572-0241.2008.02088.x. Epub 2008 Aug 27.

PMID:
18759824
31.

An effective educational strategy for improving knowledge, risk perception, and risk communication among colorectal adenoma patients.

Schroy PC 3rd, Glick JT, Wilson S, Robinson PA, Heeren TC.

J Clin Gastroenterol. 2008 Jul;42(6):708-14. doi: 10.1097/MCG.0b013e3180500318.

PMID:
18574393
32.

A new paradigm for increasing use of open-access screening colonoscopy.

Holt CL, Schroy PC 3rd.

Clin Gastroenterol Hepatol. 2008 Apr;6(4):377-8. doi: 10.1016/j.cgh.2008.02.015. No abstract available.

PMID:
18387496
33.

Has the surge in media attention increased public awareness about colorectal cancer and screening?

Schroy PC 3rd, Glick JT, Robinson PA, Lydotes MA, Evans SR, Emmons KM.

J Community Health. 2008 Feb;33(1):1-9.

PMID:
18080203
34.

Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees.

Oxentenko AS, Vierkant RA, Pardi DS, Farley DR, Dozois EJ, Hartman TE, Hough DM, Petersen WO, Klabunde CN, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ.

J Cancer Educ. 2007 Winter;22(4):219-26.

PMID:
18067433
35.

Colorectal cancer screening education, prioritization, and self-perceived preparedness among primary care residents: data from a national survey.

Oxentenko AS, Goel NK, Pardi DS, Vierkant RA, Petersen WO, Kolars JC, Flinchbaugh RT, Wilson TO, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ.

J Cancer Educ. 2007 Winter;22(4):208-18.

PMID:
18067432
36.

Patient preferences for colorectal cancer screening: how does stool DNA testing fare?

Schroy PC 3rd, Lal S, Glick JT, Robinson PA, Zamor P, Heeren TC.

Am J Manag Care. 2007 Jul;13(7):393-400.

37.

Physical activity and colorectal cancer survival: the more METS the better.

Pratap A, Schroy PC 3rd.

Gastroenterology. 2007 Jan;132(1):456-8. No abstract available.

PMID:
17241898
38.

Improved fecal DNA test for colorectal cancer screening.

Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S, Shuber A.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):111-7. Epub 2006 Dec 8.

PMID:
17161655
39.

Double-balloon endoscopy: Extending the arm of the gastroenterologist.

Mishkin DS, Schroy PC 3rd.

Gastroenterology. 2006 Sep;131(3):969-71. No abstract available.

PMID:
16952572
40.

Chromoendoscopy: a new vision for colonoscopic surveillance in IBD.

Farraye FA, Schroy PC 3rd.

Gastroenterology. 2006 Jul;131(1):323-5; discussion 325-6. No abstract available.

PMID:
16831617
41.

Fecal occult blood testing: Forget the finger!

Mishkin DS, Schroy PC 3rd.

Gastroenterology. 2005 Jul;129(1):384-6. No abstract available.

PMID:
16705773
42.

The skinny on obesity and reflux.

Jacobson BC, Schroy PC 3rd.

Gastroenterology. 2006 May;130(6):1925-6. No abstract available.

PMID:
16697760
43.

Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests.

Berger BM, Schroy PC 3rd, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR.

Clin Colorectal Cancer. 2006 Jan;5(5):338-43.

PMID:
16512992
44.

Statins and colorectal cancer risk: a new panacea?

Ahn LB, Schroy PC 3rd.

Gastroenterology. 2006 Jan;130(1):278-80. No abstract available.

PMID:
16401495
45.

Does celecoxib use increase the risk of cardiovascular events?

Oviedo JA, Schroy PC 3rd.

Gastroenterology. 2005 Oct;129(4):1348-50. No abstract available.

PMID:
16230088
46.

Early HVPG measurement and tips for acute variceal hemorrhage: is sooner really better?

Lowe R, Schroy PC.

Gastroenterology. 2005 Apr;128(4):1136-9; discussion 1139. No abstract available.

PMID:
15825100
47.

Deficiencies in knowledge and familial risk communication among colorectal adenoma patients.

Schroy PC 3rd, Lal SK, Wilson S, Heeren T, Farraye FA.

J Clin Gastroenterol. 2005 Apr;39(4):298-302.

PMID:
15758623
48.

A novel educational strategy to enhance internal medicine residents' familial colorectal cancer knowledge and risk assessment skills.

Schroy PC 3rd, Glick JT, Geller AC, Jackson A, Heeren T, Prout M.

Am J Gastroenterol. 2005 Mar;100(3):677-84. Erratum in: Am J Gastroenterol. 2006 Jan;101(1):209.

PMID:
15743368
49.

Patient perceptions of stool-based DNA testing for colorectal cancer screening.

Schroy PC 3rd, Heeren TC.

Am J Prev Med. 2005 Feb;28(2):208-14.

PMID:
15710277
50.

Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer.

Bliss CM Jr, Schroy PC 3rd.

Curr Opin Gastroenterol. 2004 Sep;20(5):468-73.

PMID:
15689681

Supplemental Content

Loading ...
Support Center